AR090915A1 - PROTEIN OF FUSION OF PROTEIN LINFOPOYETINA ESTROMAL TIMICA CANINA WITH THE REGION FC OF IGG - Google Patents
PROTEIN OF FUSION OF PROTEIN LINFOPOYETINA ESTROMAL TIMICA CANINA WITH THE REGION FC OF IGGInfo
- Publication number
- AR090915A1 AR090915A1 ARP130101495A ARP130101495A AR090915A1 AR 090915 A1 AR090915 A1 AR 090915A1 AR P130101495 A ARP130101495 A AR P130101495A AR P130101495 A ARP130101495 A AR P130101495A AR 090915 A1 AR090915 A1 AR 090915A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- igg
- region
- linfopoyetina
- estromal
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 2
- 108090000623 proteins and genes Proteins 0.000 title 2
- 230000004927 fusion Effects 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 abstract 3
- 108020001507 fusion proteins Proteins 0.000 abstract 3
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 241000282465 Canis Species 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 108010029307 thymic stromal lymphopoietin Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5418—IL-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente solicitud provee proteínas de fusión de TSLP (proteína linfopoyetina estromal tímica) canina o sus fragmentos antigénicos, con la región Fc de un IgG, junto con ácidos nucleicos que codifican estas proteínas de fusión. Además revela métodos para la preparación y el uso de estas proteínas de fusión y ácidos nucleicos. También se divulgan vectores de expresión, productos farmacéuticos y método de tratamiento o prevención de síntomas alérgicos.The present application provides fusion proteins of canine TSLP (thymic stromal lymphopoietin protein) or its antigenic fragments, with the Fc region of an IgG, together with nucleic acids encoding these fusion proteins. It also reveals methods for the preparation and use of these fusion proteins and nucleic acids. Expression vectors, pharmaceuticals and method of treatment or prevention of allergic symptoms are also disclosed.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261642563P | 2012-05-04 | 2012-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR090915A1 true AR090915A1 (en) | 2014-12-17 |
Family
ID=48325700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130101495A AR090915A1 (en) | 2012-05-04 | 2013-05-02 | PROTEIN OF FUSION OF PROTEIN LINFOPOYETINA ESTROMAL TIMICA CANINA WITH THE REGION FC OF IGG |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR090915A1 (en) |
| WO (1) | WO2013164435A2 (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE523593T1 (en) | 1997-08-01 | 2011-09-15 | Schering Corp | MAMMAL CELL MEMBRANE PROTEINS AND RELATED REAGENTS |
| EP1129190B2 (en) | 1998-11-13 | 2017-01-11 | Immunex Corporation | Human tslp dna and polypeptides |
| US6890734B2 (en) | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
| SE532251C2 (en) | 2006-11-28 | 2009-11-24 | Theravac Pharmaceuticals Ab | New formulations of TSLP for the treatment of TH2-mediated inflammatory diseases by vaccination |
| WO2008076321A1 (en) * | 2006-12-14 | 2008-06-26 | Schering Corporation | Engineered anti-tslp antibody |
| UA95329C2 (en) | 2006-12-14 | 2011-07-25 | Шеринг-Плау Лтд. | Canine thymic stromal lymphopoietin protein and uses thereof |
| BR112012010707B1 (en) * | 2009-11-04 | 2022-08-30 | Merck Sharp & Dohme Corp | ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, COMPOSITION, AND, USE OF ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF |
-
2013
- 2013-05-02 AR ARP130101495A patent/AR090915A1/en unknown
- 2013-05-03 WO PCT/EP2013/059212 patent/WO2013164435A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013164435A3 (en) | 2013-12-27 |
| WO2013164435A2 (en) | 2013-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550205A1 (en) | IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE | |
| CY1125392T1 (en) | COMPOSITIONS AND METHODS OF PROTEINS | |
| CO2019003945A2 (en) | Bispecific heterodimeric fusion proteins containing fc il-15 / il-15rα fusion proteins and pd-1 antibody fragments | |
| MX2021014863A (en) | ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME. | |
| UY36889A (en) | MOLECULES OF JOINT TO TIMICA STROMAL LYMPHOPOYETIN (TSLP) AND METHODS OF USE OF THE MOLECULES | |
| CR20180154A (en) | MOLECULES OF JOINT TO TIMICA STROMAL LYMPHOPOYETIN (TSLP) AND METHODS OF USE OF THE MOLECULES | |
| MX2019007554A (en) | BINDING PROTEINS TO THE ANTI-NEUROPYLIN ANTIGEN, AND THEIR METHODS OF USE. | |
| BR112013027829A2 (en) | anti-cd40 antibodies and method of use | |
| BR112017008165A2 (en) | single domain antibodies directed against intracellular antigens | |
| EA202091166A1 (en) | POLYPEPTIDES CONTAINING Fc WITH ALTERED GLYCOSYLATION AND REDUCED EFFECTIVE FUNCTION | |
| BR112016014810A2 (en) | FCRN ANTAGONISTS AND METHODS OF USE | |
| EA201990017A1 (en) | ANTIBODIES TO MYOSTATIN AND WAYS OF THEIR APPLICATION | |
| CO6640254A2 (en) | Method for preparing antibodies with improved properties | |
| PE20210107A1 (en) | ANTI-CD3 ANTIBODIES AND METHODS OF USE | |
| MX387560B (en) | PROCEDURE FOR IMPROVING THE SOLUBILITY OF PROTEINS AND PEPTIDES USING AN IMMUNOGLOBULIN FC FRAGMENT LINKAGE. | |
| BR112017023131A2 (en) | anti-fnc antibodies | |
| MX2020003503A (en) | ONCOSTATIN RECEPTOR ANTIGEN-BINDING PROTEINS M. | |
| EA202091239A1 (en) | FUSION PROTEIN BASED ON A THERAPEUTIC ENZYME WITH A NEW STRUCTURE AND ITS APPLICATION | |
| MX373277B (en) | MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES. | |
| EA202090084A1 (en) | NEW THERAPEUTIC ENZYME Fusion PROTEIN AND ITS APPLICATION | |
| MX2018003445A (en) | Expression of fc-containing proteins. | |
| BR112015017981A2 (en) | human antibody specific for human metapneumovirus, or antigen binding fragment thereof, its use and pharmaceutical composition comprising it, as well as isolated nucleic acid, recombinant expression vector and host cell | |
| UY37752A (en) | PROTEINS OF UNION TO THE ANTIGEN ANTI-JAGGED1 | |
| CR20150477A (en) | IL-22 POLYPEPTIDES AND IL-22 FC FUSION PROTEINS AND METHODS OF USE | |
| AR090915A1 (en) | PROTEIN OF FUSION OF PROTEIN LINFOPOYETINA ESTROMAL TIMICA CANINA WITH THE REGION FC OF IGG |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |